These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32134701)

  • 21. Insights From Building a New National Cancer Institute Community Oncology Research Program Site.
    Saphner T; Thompson MA; Planton S; Singh M; Glandt N; Robinson L; DeBartolo J
    WMJ; 2016 Aug; 115(4):191-5. PubMed ID: 29099156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Criteria for the use of omics-based predictors in clinical trials.
    McShane LM; Cavenagh MM; Lively TG; Eberhard DA; Bigbee WL; Williams PM; Mesirov JP; Polley MY; Kim KY; Tricoli JV; Taylor JM; Shuman DJ; Simon RM; Doroshow JH; Conley BA
    Nature; 2013 Oct; 502(7471):317-20. PubMed ID: 24132288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health-related quality of life and symptom management research sponsored by the National Cancer Institute.
    Minasian LM; O'Mara AM; Reeve BB; Denicoff AM; Kelaghan J; Rowland JH; Trimble EL;
    J Clin Oncol; 2007 Nov; 25(32):5128-32. PubMed ID: 17991932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary Care Research Team Assessment (PCRTA): development and evaluation.
    Carter YH; Shaw S; Macfarlane F
    Occas Pap R Coll Gen Pract; 2002 Feb; (81):iii-vi, 1-72. PubMed ID: 12049028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations.
    Lieberman R; Nelson WG; Sakr WA; Meyskens FL; Klein EA; Wilding G; Partin AW; Lee JJ; Lippman SM
    Urology; 2001 Apr; 57(4 Suppl 1):4-27. PubMed ID: 11295590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What Can Be Done to Improve Research Biopsy Quality in Oncology Clinical Trials?
    Ferry-Galow KV; Datta V; Makhlouf HR; Wright J; Wood BJ; Levy E; Pisano ED; Tam AL; Lee SI; Mahmood U; Rubinstein LV; Doroshow JH; Chen AP
    J Oncol Pract; 2018 Oct; 14(11):JOP1800092. PubMed ID: 30285529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adequacy of core needle biopsy specimens and fine-needle aspirates for molecular testing of lung adenocarcinomas.
    Schneider F; Smith MA; Lane MC; Pantanowitz L; Dacic S; Ohori NP
    Am J Clin Pathol; 2015 Feb; 143(2):193-200; quiz 306. PubMed ID: 25596245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the collection approaches of 2 large thyroid fine-needle aspiration practices reveals differing advantages for cytology and molecular testing adequacy rates.
    Landau MS; Pearce TM; Carty SE; Wolfe J; Yip L; McCoy KL; LeBeau SO; Tublin ME; Ohori NP
    J Am Soc Cytopathol; 2019; 8(5):243-249. PubMed ID: 31543223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical trial cytology: Use of on-site evaluation of small biopsy and FNA samples for clinical trials and biomarker research studies.
    Manzo JL; Cuda J; Pantanowitz L; Xing J; Yu J; Beasley HS; Dhir R; Monaco SE
    Cancer Cytopathol; 2018 Jul; 126(7):. PubMed ID: 29719135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. United States military contributions to the National Cancer Institute.
    Sarvis JA; Thompson IM
    Urol Oncol; 2009; 27(5):558-61. PubMed ID: 19720303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Collection and Handling of Thoracic Small Biopsy and Cytology Specimens for Ancillary Studies Guideline from the College of American Pathologists (CAP): implications for the cytology community.
    VanderLaan PA
    J Am Soc Cytopathol; 2020; 9(4):286-290. PubMed ID: 32439185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of the pulmonologist in ordering post-procedure molecular markers in non-small-cell lung cancer: implications for personalized medicine.
    Murgu S; Colt H
    Clin Lung Cancer; 2013 Nov; 14(6):609-26. PubMed ID: 24188629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transforming the Early Drug Development Paradigm at the National Cancer Institute: The Formation of NCI's Experimental Therapeutics Clinical Trials Network (ETCTN).
    Massett HA; Mishkin G; Moscow JA; Gravell A; Steketee M; Kruhm M; Han SH; Barry B; Montello M; Zwiebel J; Abrams JS; Doroshow JH; Ivy SP
    Clin Cancer Res; 2019 Dec; 25(23):6925-6931. PubMed ID: 31439585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference.
    Hall WA; Bergom C; Thompson RF; Baschnagel AM; Vijayakumar S; Willers H; Li XA; Schultz CJ; Wilson GD; West CML; Capala J; Coleman CN; Torres-Roca JF; Weidhaas J; Feng FY
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):274-284. PubMed ID: 28964588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous biopsy of the liver and kidney by using coaxial technique: adequacy of the specimen obtained with three different needles in vitro.
    Hopper KD; Grenko RT; TenHave TR; Hartzel J; Sturtz KW; Savage CA
    AJR Am J Roentgenol; 1995 Jan; 164(1):221-4. PubMed ID: 7998543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cooperative Group Trials in the Community Setting.
    Lloyd Wade J; Petrelli NJ; McCaskill-Stevens W
    Semin Oncol; 2015 Oct; 42(5):686-92. PubMed ID: 26433550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patients with Advanced Non-Small Cell Lung Cancer: Are Research Biopsies a Barrier to Participation in Clinical Trials?
    Lim C; Sung M; Shepherd FA; Nouriany N; Sawczak M; Paul T; Perera-Low N; Foster A; Zawisza D; Feld R; Liu G; Leighl NB
    J Thorac Oncol; 2016 Jan; 11(1):79-84. PubMed ID: 26762742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility of a Centralized Clinical Trials Coverage Analysis: A Joint Initiative of the American Society of Clinical Oncology and the National Cancer Institute.
    Szczepanek CM; Hurley P; Good MJ; Denicoff A; Willenberg K; Dawson C; Kurbegov D
    J Oncol Pract; 2017 Jun; 13(6):395-400. PubMed ID: 28481681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An overview of the NCI precision medicine trials-NCI MATCH and MPACT.
    Do K; O'Sullivan Coyne G; Chen AP
    Chin Clin Oncol; 2015 Sep; 4(3):31. PubMed ID: 26408298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.